HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,580
-670 (-4.12%)
At close: Feb 6, 2026
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 218.78 billion as of February 6, 2026. Its market cap has decreased by -38.78% in one year.
Market Cap
218.78B
Enterprise Value
209.12B
Revenue
36.10B
Ranking
n/a
PE Ratio
462.87
Stock Price
15,580.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 218.78B, an increase of 159.59%. That is a compound annual growth rate of 9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 218.78B | -2.87% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 249.07B |
| Daewon Pharmaceutical | 244.13B |
| Chong Kun Dang Holdings | 235.65B |
| Samjin Pharmaceuticals | 235.35B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Samil Pharmaceutical Co.,Ltd | 229.49B |
| AptaBio Therapeutics | 216.32B |
| REYON Pharmaceutical | 212.57B |